6.37
+0.16%
Close of 9 Nov 2026, in USD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Lifecore Biomedical
From its filings with the US Securities and Exchange Commission
Lifecore Biomedical is based in Chaska, Minnesota and is incorporated in Delaware. Its shares trade on Nasdaq under the ticker LFCR. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 25 May 2025, it reported revenue of $128.9m and a net loss of $38.7m. At that date it held total assets of $239.3m and shareholders' equity of $1.3m.
Lifecore Biomedical, Inc. and its subsidiaries (“Lifecore”, the “Company”, “we” or “us”), located in Chaska, Minnesota, is a fully integrated contract development and manufacturing organization (“CDMO”) that offers highly differentiated clinical and commercial capabilities in the development, cGMP manufacturing and aseptic filling of complex formulations and highly viscous sterile injectable pharmaceutical drug or medical device products in syringes, vials and cartridges, across a wide variety of modalities. Lifecore has become a leading U.S. manufacturer of pharmaceutical-grade, non-animal-sourced hyaluronic acid (“HA”) using our proprietary, fermentation-based HA process that we developed in 1981. We manufacture HA in bulk form as well as for use in formulated and filled syringes and vials for our customers’ injectable products used in treating a broad spectrum of medical conditions and procedures, including ophthalmic and orthopedic applications. We have leveraged this expertise in HA fermentation, manufacturing and aseptic formulation and filling to also develop highly viscous non-HA-based sterile injectable products with our customers for multiple applications.
Quoted from its 10-K, filed 7 Aug 2025. Read the filing on SEC.gov ↗
Company facts
- Sector
- Consumer Staples
- Industry
- Food Products
- Listed since
- 16 Feb 1996
- Employees
- 406
- Website
- landec.com ↗
- Head office
- 3515 LYMAN BOULEVARD, CHASKA, MN, 55318
- Incorporated in
- DE
- Classification
- Pharmaceutical Preparations
- Filer status
- Accelerated filer<br>Smaller reporting company
Leadership
Pay as last reported
- Ms. Katrina HoudeIndependent Chairman of the Board$305,111
- Mr. Paul JosephsPresident, Chief Executive Officer, Director, since 2024$1.1m
- Mr. Ryan LakeChief Financial Officer$4.2m
- Mr. Thomas SalusChief Legal and Administrative Officer , Secretary$4.1m
- Mr. Humberto AntunesIndependent Director$203,910
- Mr. Jason AryehIndependent Director$185,477
- Mr. Paul JohnsonIndependent Director$206,117
- Mr. Christopher KiperIndependent Director$205,578
- Mr. Matthew KorenbergIndependent Director$188,569
- Mr. Nelson ObusIndependent Director$215,003
- Mr. Joshua SchechterIndependent Director$243,369
- Ms. Stephanie DiazInvestor Relations, since 2024
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 27
- Environment
- 9
- Social
- 51
- Governance
- 22
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Strong market presence and well-established brand reputation.
- Diversified product portfolio across different industries.
- Robust research and development capabilities, leading to innovative and high-quality products.
Weaknesses
- Reliance on a few major customers, making the company vulnerable to their changing demands or loss of contracts.
- Limited geographic presence, mainly operating within specific regions.
- Higher production costs compared to some competitors.
Opportunities
- Growing demand for environmentally friendly products, providing an opportunity for the company's sustainable packaging solutions.
- Expansion into new markets and industries, leveraging existing expertise and capabilities.
- Acquisition or partnership opportunities to enhance product offerings or access new distribution channels.
Threats
- Intense competition from both established players and new entrants in the industry.
- Economic downturns or fluctuations in the market affecting consumer spending patterns.
- Increasing regulations and compliance requirements impacting product development and manufacturing processes.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.